Eli Lilly Offers Zepbound in Cheaper Vials to Boost Demand
#WeightLoss #PharmaceuticalsAmerican pharmaceutical company Eli Lilly has introduced higher doses of its weight-loss drug Zepbound in vials, selling them at a discount of $150 compared to injector pens. This move aims to boost demand for the drug and compete with Novo Nordisk's Wegovy. read more
Trump's Nomination of RFK Jr Sparks Concern and Stock Decline
#RFKJr #PharmaceuticalsInvestors are selling pharmaceutical stocks as Trump nominates vaccine skeptic RFK Jr to lead the US Department of Health and Human Services. RFK Jr's anti-vaccine stance and health conspiracy theories have drawn criticism, causing shares of major drug companies to fall. read more